These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5743699)

  • 1. Vincristine (NSC-67574) symposium--summary and prospectives.
    Armstron JG
    Cancer Chemother Rep; 1968 Jun; 52(4):527-35. PubMed ID: 5743699
    [No Abstract]   [Full Text] [Related]  

  • 2. Vincristine (NSC-67574) therapy for acute leukemia in children.
    Haggard ME
    Cancer Chemother Rep; 1968 Jun; 52(4):477-9. PubMed ID: 4914916
    [No Abstract]   [Full Text] [Related]  

  • 3. Third and fourth remission induction with prednisone (NSC-10023) and vincristine (NSC-67574) in children with acute leukemia.
    Starling K; Lane DM; Sutow WW; Monto RW; Thurman WG
    Cancer Chemother Rep; 1970 Oct; 54(5):293-4. PubMed ID: 5514615
    [No Abstract]   [Full Text] [Related]  

  • 4. Vincristine (NSC-67574) in the treatment of children with acute leukemia.
    Evans AE
    Cancer Chemother Rep; 1968 Jun; 52(4):469-71. PubMed ID: 5743693
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination therapy including vincristine (NSC-67574) for malignant solid tumors in children.
    Pratt CB; James DH; Holton CP; Pinkel D
    Cancer Chemother Rep; 1968 Jun; 52(4):489-95. PubMed ID: 5743695
    [No Abstract]   [Full Text] [Related]  

  • 6. Vincristine therapy.
    Finkel HE
    N Y State J Med; 1967 Sep; 67(18):2474-8. PubMed ID: 4864536
    [No Abstract]   [Full Text] [Related]  

  • 7. Remission induction in childhood leukemia with second course vincristine (NSC-67574) and prednisone (NSC-10023) therapy.
    Cancer Chemother Rep; 1970 Apr; 54(2):113-8. PubMed ID: 4946001
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of vincristine (NSC-67574) against refractory leukemia in children.
    Karon M
    Cancer Chemother Rep; 1968 Jun; 52(4):473-6. PubMed ID: 5270581
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I and preliminary phase II evaluation of adriamycin (NSC 123127).
    Bonadonna G; Monfardini S; De Lena M; Fossati-Bellani F; Beretta G
    Cancer Res; 1970 Oct; 30(10):2572-82. PubMed ID: 5474180
    [No Abstract]   [Full Text] [Related]  

  • 10. Vincristine in the treatment of acute leukemia in children.
    Heyn RM; Beatty EC; Hammond D; Louis J; Pierce M; Murphy ML; Severo N
    Pediatrics; 1966 Jul; 38(1):82-91. PubMed ID: 5936884
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with vincristine (NSC-67574) in tumors of the central nervous system and other malignant diseases.
    Smart CR; Ottoman RE; Rochlin DB; Hornes J; Silva AR; Goepfert H
    Cancer Chemother Rep; 1968 Dec; 52(7):733-41. PubMed ID: 5743710
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vincristine and prednisone treatment of acute leukemias].
    Starkiewiczowa J; Korycka A; Mezyk B
    Pediatr Pol; 1972 Sep; 47(9):1083-8. PubMed ID: 5082257
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of cytosine arabinoside (NSC-63878) synchronization plus vincristine (NSC-67574), prednisone (NSC-10023), and L-asparaginase (NSC-109229) for remission induction in advanced acute leukemia in children.
    Sutow WW; Thomas D; Steuber CP; Pullen J; Vats T; Bryan JH; Morgan SK
    Cancer Treat Rep; 1976 May; 60(5):591-4. PubMed ID: 991148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of vincristine in the therapy of acute leukosis. Clinical research on 27 cases of acute leukosis].
    Storti E; Traldi A; Bellesia L; Artusi T
    Minerva Med; 1966 Mar; 57(25):1111-6. PubMed ID: 5932013
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vincristine sulfate in the treatment of acute leukemia in childhood].
    Colarizi A; Stegagno G; Digilio G; Multari G
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):209-19. PubMed ID: 5241849
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electroencephalographic observations after therapy with vincristine (author's transl)].
    Dieterich E; Goebel B; Gutjahr P
    Monatsschr Kinderheilkd (1902); 1978 Dec; 126(12):709-10. PubMed ID: 732820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).
    Gasparini M; Bellani FF; Musumeci R; Bonadonna G
    Cancer Chemother Rep; 1974; 58(3):365-70. PubMed ID: 4601666
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical aspects of childhood leukemia].
    Kawamoto K
    Nihon Ketsueki Gakkai Zasshi; 1966 Aug; 29(4):609-14. PubMed ID: 6008916
    [No Abstract]   [Full Text] [Related]  

  • 19. Pediatric oncology.
    Jaffe N
    Am J Med Technol; 1973 Sep; 39(9):345-53. PubMed ID: 4356909
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy with cytosine arabinoside, daunomycin and vincristine in refractory leukemia of childhood (author's transl)].
    Akatsuka J; Ueda Y; Ohmi K; Shike S; Nishimura K
    Rinsho Ketsueki; 1975 Oct; 16(10):931-5. PubMed ID: 1239527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.